1.
Sarma A, Kataki A, Rai A, Hazarika M, Roy P, Kalita M, Deka M, Chattopadhyay I. Promoter Hypermethylation of ATG16L2, TFAP2A, EBF2, Calcitonin, ABL1 Kinase Domain T315I Mutation Association with Imatinib Therapy Resistance and Median Survival in CML Patients of North-East India. apjcc [Internet]. 17Feb.2023 [cited 18Apr.2024];8(1):35-2. Available from: http://waocp.com/journal/index.php/apjcc/article/view/967